The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance. (Q34094150)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20093562%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20093562%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

1 reference

0 references

1 reference

1 reference

metabolic dysfunction–associated steatotic liver disease

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20093562%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Frank G. Schaap

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20093562%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Tim C M A Schreuder

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20093562%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Hendrik A Marsman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20093562%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Jochem R van Werven

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20093562%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Aart J Nederveen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20093562%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Peter L M Jansen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20093562%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

21 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20093562%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Physiology - Gastrointestinal and Liver Physiology

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20093562%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

298

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20093562%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20093562%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

G440-5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20093562%20AND%20SRC:MED&resulttype=core&format=json

The metabolic syndrome--a new worldwide definition

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

Standards of medical care in diabetes--2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

The FGF family: biology, pathophysiology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

Bile acids: regulation of synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

Experimental non-alcoholic fatty liver disease results in decreased hepatic uptake transporter expression and function in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

The role of fatty acids in the development and progression of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

The enterohepatic circulation of bile acids in mammals: form and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

Significance of plasma 7alpha-hydroxy-4-cholesten-3-one and 27-hydroxycholesterol concentrations as markers for hepatic bile acid synthesis in cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

Mini-review: endocrine actions of fibroblast growth factor 19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

Improved HPLC analysis of serum 7alpha-hydroxycholest-4-en-3-one, a marker of bile acid malabsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leptin treatment in ob/ob mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

Adipokines in liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

Obesity and post-prandial lipid metabolism. Feast or famine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

Regulation of bile acid synthesis under reconstructed enterohepatic circulation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

The enzymes, regulation, and genetics of bile acid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

Fibroblast growth factor-19: development, analytical characterization and clinical evaluation of a new ELISA test

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009

Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00322.2009